Skindex-29 to Determine Quality of Life and Emotional Factors in Dermatological Conditions

Authors

  • Desiree Saimbi Department of Psychiatry, People's College of Medical Sciences, Bhopal (M.P). Mob : 7354547713. E-mail: dsaimbi@gmail.com.
  • MCVK Raju Department of Psychiatry, People's College of Medical Sciences, Bhopal (M.P).
  • Vaibhav Dubey Department of Psychiatry, People's College of Medical Sciences, Bhopal (M.P).
  • Vivek Kumar Dey Department of Dermatology, People's College of Medical Sciences, Bhopal (M.P).

Keywords:

Quality of life, anxiety, depression, skindex-29, skin diseases.

Abstract

Though rarely fatal, skin diseases are known to be associated with increased psychiatric morbidity and considerable impairment of quality of life (QoL). Health Related Quality of Life (HRQoL) in skin diseases can be assessed by generic or skin speciï¬c instruments. One hundred sixty patients with a range of dermatological diagnoses were studied on a cross sectional observational paradigm. Skindex- 29, a skin speciï¬c instrument, was used to assess QoL, while anxiety and depression were assessed by Anxiety Status Inventory (ASI) and Depression Status Inventory (DSI), respectively. Sixty two patients (39%) had impaired QoL out of which 37(60%) had severe impairment. 11 patients (7%) had anxiety and 22(14%) had depression in the mild to moderate range. Gender, anxiety, depression and effect on appearance seem to be not related to impaired QoL. Further large scale studies are needed to ascertain the factors impinging on the QoL of dermatologically ill patients.

Keywords: Quality of life, anxiety, depression, skindex-29, skin diseases.

 

References

Basra KAM, Shahrukh M (2009). Burden o f s k i n d i s e a s e s . E x p e r t R e v Pharmacoeconomics Outcomse Res 9(3):271-283.

Hay RJ, Johns NE, Williams HC, et al (2014). The global burden of skin diseases in 2010: An analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134:1527-1534.

Chren MM, Rebecca LJ, Linda QM, et al (1996). Skindex, a quality-of-life measure for patients with skin diseases: Reliability, validity and responsiveness. J Invest Dermatol 107:707-713.

Ghosh S, Behere V Rishikesh, Sharma PVSN, Sreejayan K (2013). Psychiatric evaluation in dermatology: An overview. Indian J Dermatol 58:39-43.

Picardi A, Amerio P, Baliva G, et al (2004). Recognition of depressive and anxiety disorders in dermatological out patients. Acta Derm Venereol 84(3): 213-217.

Schmid-Ott G, Steen T (2010). Skin Disorders and Quality of Life. In: I n t e r n a t i o n a l E n c y c l o p e d i a o f Rehabilitation. Stone JH and Blovin M e d s . h t t p : / / c i r r i e . b u f f a l o . e d u / encyclopedia/en/article/152/2010.

S i b e l M , A l t u n a y I K ( 2 0 0 6 ) . Psychodermatology : A collaborative subject of psychiatry and dermatology. Turkish J Psychiatry 17(4): 305-313.

Seyhan M, Aki T, Karincaoglu Y, Ozcan H (2006). Psychiatric morbidity in dermatology patients: Frequency and results of consultations. Indian J Dermatol 51(1):18-22.

Kiec-Swierczynska M, Dudek B, Krecirz B, et al (2006). The role of psychological factors and psychiatric disorders in skin diseases. Med Pr 57(6): 551-555.

Shumaker SA, Naughton MJ (1995). The international assessment of health related quality of life. In: The International Assessment of Health Related Quality of Life: Theory, Translation, Measurement and Analysis. Shumaker SA, Berzon RA eds. New York : Rapid Communications, 3-10.

Higaki Y, Kawamoto K, Kamo T, et al (2002). The Japanese version of Skindex- 16: A brief quality-of-life measure for patients with skin diseases. J Dermatol 29:693-698.

Chren MM (2010). Interpretation of quality-of-life scores. J Invest Dermatol 130:1207-1209.

Hughes JE, Barraclough BM, Hamblin LG, White JE (1983). Psychiatric symptoms in dermatology patients. Br J Psychiatry 143:1-54.

Picardi A, Abeni D, Melchi CF, et al ( 2000 ) . Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol 143: 983-991.

Zachariae R, Zachariae C (2004). Psychiatric symptoms and quality of life of dermatological outpatients and hospitalized dermatological patients. Acta Derm Veneriol 84:205-212.

Gupta MA, Gupta AK, Ellis CN, Koblenzer CS (2005). Psychiatric evaluation in dermatology patient's. Dermatologic clinics 23(4) : 591-599.

Basavaraj KH, Navya MA, Rashmi R (2010). Relevance of psychiatry in dermatology. Indian J Psychiatry 52(3) : 270-275.

Lee YW, Park EJ, Kwon IH, et al (2010). Impact of psoriasis on quality of life. Ann Dermatol 22(4):389-396.

Kumar S, Kachhawha D, Das Koolwal GD, et al (2011). Psychiatric morbidity in psoriasis patients : a pilot study. Indian J Dermatol Venereol Leprol 77:625.

Mattoo SK, Hande S, Kaur I, et al (2001). Psychiatric morbidity in vitiligo and psoriasis. J Dermatol 28(8): 424-432.

Marina RM, Desire DM, Miguel SR, et al ( 2012 ) . Assessment of psychiatric disorders in vitiligo. Considerations for our daily practice. Our Dermatol online 3(1):61-62.

Klassen AF, Newton JN, Mallon E (2000). Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease speciï¬c measures. JAm Acad Dermatol 43(2):229- 233.

Pruthi GK, Babu N (2012). Physical and psychosocial impact of acne in adult females. Indian J Dermatol 57(1):26-29.

Choudhary S, Raju MSVK, Dubey BL (2001). Alopecia Areata : Evaluation using psychological tests and somatic ink blot test. J Pr Psy and Mental Health 8:143-148.

Lamieux J, Maunsel E, Provencher (2008). Chemotherapy-induced alopecia and effects on quality of life among woman with breast cancer. Psycho- oncology 17:317-328.

Ujwala PC, Dincy Peter CV, Pulimood SA (2013). Impact of hand eczema severity on quality of life. Indian Dermatol online 4(2):102-105.

Joseph GA, Sunder Rao PSS (1999). Impact of leprosy on the quality of life. Bulletin of WHO 77(6):515-517.

Sampogna F, Picardi A, Chren MM, et al (2004). Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosomatic Medicine 66:620-624.

Abolfotouh MA, Al-khowailed MS, Suliman WE, et al (2012). Quality of life in patients with skin diseases in central Saudi Arabia. Int J Gen Medicine 5: 633- 642.

Ponarovsky B, Amital D, Lazarov A, et al (2011). Anxiety and depression in patients with allergic and non-allergic cutaneous disorders. Int J Dermatol 50(10) : 1217-1222.

Zung WW (1971). A rating instrument for anxiety disorders. Psychosomatics 12:371-379.

Zung WW (1972). The depression status inventory : an adjunct to the self-rating depression scale. J Clin Psychol 28:539- 543.

Chren MM, Lasek RJ, Flocke SA, Z y z a n s k i S J ( 1 9 9 7 ) . I m p r o v e d discriminative and evaluative capability of a reï¬ned version of Skindex, a quality- of-life instrument for patients with skin disorders. Arch Dermatol 133(11):1433- 1440.

Prinsen Cecilea AC, Lindeboom R, De corti J (2011). Interpretation of skindex - 29 scores-cutoffs for mild moderate and severe impairment of health related quality of life. J Invest Dermatol 131:1935-1947.

Tan JK, Vassey K, Furg KY (2001). Beliefs and perceptions of patients with acne. JAm Acad Derm 44(3):439-445.

Both H, Essink-Bot ML, Busschback J, Nijsten T (2007). Critical review of generic and dermatology-speciï¬c health- related quality of life instruments. J Invest Dermatol 127:2726-1239.

Bae JM, Beoman H, Hong Surlee (2012). Prevalence of common skin diseases and their associated factors among military personnel in Korea-A cross sectional study. J Korean Med Sci 27:1248-1254.

Peyri J, Lleonart M (2007). Clinical and therapeutic proï¬le of quality of life of patients with seborrheic dermatitis. Acats Dermosiï¬liogr 98:476-482.

Kopel E, Levi A, Harari M, et al (2013). Effects of dead sea climatotherapy for psoriasis on quality of life. IMAJ 15(2) : 99-102.

Kosaraju SKM, Reddy KS, Naresh V, et al (2015). Psychological morbidity among dermatological patients in rural setting. Indian J Dermatol 60(6): 635.

Sanclemente G, Burgos C, Nova J, et al (2017). The impact of skin diseases on quality of life : A multicenter study – original article. Actas Dermosiï¬liogr 108(3): 244-252.

Jindal KC, Singh GP, Mohan V (2013). Psychiatric morbidity among inmates of leprosy homes. Indian J Psychol Med 35:335-340.

Aslam R, Qadir A, Asad F (2007). Psychiatric morbidity in dermatological outpatients : an issue to be recognized. J Pakistan Assoc Dermatologists 17 : 235- 239.

Abebe G, Ayano G, Andargie G, et al (2016). Prevalence and factors associated with anxiety among patients with common skin disease on follow up at Alert Referral Hospital, Addis Ababa, Ethiopia. J Psychiatry 19(3) : 367.

Yazici K, Baz K, Yazici AE, et al (2004). Disease speciï¬c quality of life is associated with anxiety and depression in patients with acne. JEADV 18(4) : 435- 439.

Staubach P, Eckhardt-Henn, Dechene M, et al (2006). Quality of life in patients with chronic urticaria in differentially impaired patients and determined by psychiatric morbidity. Br J Dermatology 154(2) : 294- 298.

Deaver DM (2013). Predictors of quality of life in patients with cutaneous l y m p h o m a . T h e s i s . http://scholarcommons@usf.edu.

Schmit JM, Ford DE (2007). Role of depression in quality of life for patients with psoriasis. Dermatology 215(1) : 17- 27.

Basher K, Nasser RD, Rao SU (2010). Depression in adult dermatology patients. JCPSP 20(12) : 811-813.

Sharma S, Bassi R, Singh A (2011). A comparative study of depression and anxiety in psoriasis and other skin diseases. J Pakistan Assoc Dermatologists 24(4):235-240.

Solgajova A, Sollar T, Vorosova G, et al (2016). The incidence of anxiety, depression and quality of life in patients with dermatological diseases. Cent Eur Nurs Midw 7(3): 467-483.

Chren MM ( 2012 ) . The skindex instruments to measure the effects of skin diseases on quality of life. Dermatol Clin 30(2) : 231-236.

Nijsten T, Sampogna F, Abeni D (2009). Categorization of Skindex -29 scores using mixture analysis. Dermatology 218:151-154.

Published

2017-01-01

Issue

Section

ARTICLES